[Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia].

Yan Liu, Xiaoyan Ke, Jun Ma, Zhixiang Shen, Xiaohong Zhang, Xin Du, Yi-Ming Zhao, Jing-qiao Lü, Zhao-min Zhan, Xiao-ying Zeng, Xiaohua Xu, Zesheng LuPubMed 2005

Abstract

The efficacy of IDA in the treatment of acute leukemia is comparable to that of zevodas. Both have similar toxic side effects.
BibTeX
@inproceedings{liu2005multi,
  author = {Yan Liu and Xiaoyan Ke and Jun Ma and Zhixiang Shen and Xiaohong Zhang and Xin Du and Yi-Ming Zhao and Jing-qiao Lü and Zhao-min Zhan and Xiao-ying Zeng and Xiaohua Xu and Zesheng Lu},
  title = {{[Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia].}},
  booktitle = {PubMed},
  year = {2005},
}

Loading related content...

Figure